Lingyan Wang
Impact in
- Pharmacology top 5%
- Microbial Natural Products and Biosynthesis
- Fungal Biology and Applications
- Cholinesterase and Neurodegenerative Diseases
-
- interferon and immune responses
Papers in
- Pharmacology 18
- Microbial Natural Products and Biosynthesis 8
- Fungal Biology and Applications 5
- Co-authors
- Shitao Li (6 shared papers)Martin E. Dorf (3 shared papers)Gui‐Yang Xia (17 shared papers)Bishi Fu (2 shared papers)Yuzhuo Wu (15 shared papers)Sheng Lin (17 shared papers)Jens C. Schwamborn (1 shared paper)Hao Ding (1 shared paper)
- Journals
- Blood (3 papers)Bioorganic & Medicinal Chemistry Letters (3 papers)Journal of Natural Products (3 papers)Frontiers in Oncology (2 papers)Journal of Asian Natural Products Research (2 papers)
- Partner nations
- ChinaUnited StatesCanada
In The Last Decade
Lingyan Wang
105 papers receiving 1.3k citations
Peers
Comparison fields: 5 of 120
- Pharmacology 158
- Immunology 199
- Molecular Biology 469
- Complementary and alternative medicine 45
- Cancer Research 78
Countries citing papers authored by Lingyan Wang
This map shows the geographic impact of Lingyan Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lingyan Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lingyan Wang more than expected).
Fields of papers citing papers by Lingyan Wang
This network shows the impact of papers produced by Lingyan Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lingyan Wang. The network helps show where Lingyan Wang may publish in the future.
Co-authors
The 25 scholars most cited alongside Lingyan Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 113 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2015 | 137 | |
| 2 | 2009 | 90 | |
| 3 | 2023 | 67 | |
| 4 | 2017 | 55 | |
| 5 | 2013 | 49 | |
| 6 | 2018 | 42 | |
| 7 | 2018 | 41 | |
| 8 | 2019 | 40 | |
| 9 | 2023 | 36 | |
| 10 | 2017 | 36 | |
| 11 | 2020 | 35 | |
| 12 | 2016 | 31 | |
| 13 | 2014 | 30 | |
| 14 | 2020 | 29 | |
| 15 | 2023 | 25 | |
| 16 | 2014 | 24 | |
| 17 | 2018 | 23 | |
| 18 | 2020 | 22 | |
| 19 | 2013 | 21 | |
| 20 | 2018 | 19 |
About Lingyan Wang
Lingyan Wang is a scholar working on Molecular Biology, Pharmacology, Public Health, Environmental and Occupational Health, Organic Chemistry and Immunology, having authored 113 papers that have together received 1.3k indexed citations. Recurring topics across this work include Microbial Natural Products and Biosynthesis (8 papers), interferon and immune responses (5 papers), Acute Lymphoblastic Leukemia research (5 papers), Fungal Biology and Applications (5 papers), Chemical synthesis and alkaloids (5 papers), Acute Myeloid Leukemia Research (5 papers), Reproductive Biology and Fertility (5 papers) and Influenza Virus Research Studies (4 papers). The work is most often cited by research in Pharmacology (158 citations), Immunology (199 citations), Molecular Biology (469 citations), Complementary and alternative medicine (45 citations) and Cancer Research (78 citations). Lingyan Wang has collaborated with scholars based in China, United States and Canada. Frequent co-authors include Shitao Li, Martin E. Dorf, Gui‐Yang Xia, Bishi Fu, Yuzhuo Wu, Sheng Lin, Jens C. Schwamborn, Hao Ding, Huan Xia and Yanan Wang. Their work appears in journals such as Blood, Bioorganic & Medicinal Chemistry Letters, Journal of Natural Products, Frontiers in Oncology and Journal of Asian Natural Products Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.